topic

1178 Tumor-immune cell targeting chimeras (TICTACs): targeted immune reprogramming of the tumor microenvironment
Mariko Morimoto, Nicholas A Till, Carolyn R Bertozzi

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1298; DOI: 10.1136/jitc-2023-SITC2023.1178
905 Moving from awareness to adoption: live virtual training equips community physicians to select first-line immunotherapy for advanced NSCLC
Kadrin Wilfong, Michael Beyer, Heather Drew

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1007; DOI: 10.1136/jitc-2023-SITC2023.0905
906 Leveraging CME to address social determinants of health in immunotherapy selection for advanced NSCLC: empowering clinicians for equitable care
Kadrin Wilfong, Michael Beyer, Heather Drew

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1008; DOI: 10.1136/jitc-2023-SITC2023.0906
907 Enhancing multidisciplinary collaboration for effective integration of perioperative immunotherapies in stage I-III resectable NSCLC: a continuing medical education (CME) approach
Kadrin Wilfong, Michael Beyer, Heather Drew

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1009; DOI: 10.1136/jitc-2023-SITC2023.0907
908 The impact of a full-time live harp musician on the oncology floors in improving the patient’s and caregiver’s well-being
Fnu Anamika, Akshit Chitkara, Rushin Patel

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1010; DOI: 10.1136/jitc-2023-SITC2023.0908
909 Impact of one-on-one video education in increasing turnover for colorectal carcinoma screening – a systemic review
Akshit Chitkara, Femina Patel, Fnu Anamika, Rushin Patel, Ujjwal Soni, Nandini Gowda

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1011; DOI: 10.1136/jitc-2023-SITC2023.0909
910 Development and user testing of a website with information for cancer patients who have pre-existing autoimmune disease and are considering immune checkpoint inhibitors (ICIs)
Maria A Lopez-Olivo, Maria E Suarez-Almazor, Gabrielle F Duhon, McKenna Erck, Cassandra Calabrese, Mehmet Altan, Hussain Tawbi, Alexa Meara, Clifton Bingham, Adi Diab, Viola B Leal, Robert J Volk

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1012; DOI: 10.1136/jitc-2023-SITC2023.0910
911 Improved lifelines needed for all lines: real-world treatment patterns and attrition rates in US patients with non-driver mutation metastatic non-small cell lung cancer
Adam Schoenfeld, Chen Hu, Ravi Rajaram, Josephine Feliciano, Urmila Chandran, Charlene Wong, U Hariharan, Iftekhar Kalsekar, Tianyi Wang, Qing Huang, Aisha Hasan

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1013-A1014; DOI: 10.1136/jitc-2023-SITC2023.0911
912 A comparison of 37+ immune populations in whole blood by CyTOF® flow cytometry collected with 4 different preservation reagents
Geneve Awong, Deeqa Mahamed, Vinicius Motta, Stephen Li, Kevin Brown, Thirumahal Selvanantham

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1015; DOI: 10.1136/jitc-2023-SITC2023.0912
913 Tumor immune micro-environment (TIME) Atlas for prostate cancer bone metastasis
Kenneth Canubas, Michael Xu, William Kelly, Jennifer Marte, Houssein Abdul Sater, James L Gulley, Wiem Lassoued

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1016; DOI: 10.1136/jitc-2023-SITC2023.0913

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages